BWL
ASND icon

Bogart Wealth LLC’s Ascendis Pharma A/S ASND Stock Holding History

Bogart Wealth LLC’s Portfolio ASND Stock Details ASND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-34
Closed -$4.64K – 1130
2024
Q2 		$4.64K Hold
34
– – ﹤0.01% 806
2024
Q1 		$5.14K Hold
34
– – ﹤0.01% 765
2023
Q4 		$4.28K Hold
34
– – ﹤0.01% 781
2023
Q3 		$3.18K Hold
34
– – ﹤0.01% 816
2023
Q2 		$3.04K Hold
34
– – ﹤0.01% 817
2023
Q1 		$3.65K Buy
+34
New +$3.89K ﹤0.01% 795

Other funds holding ASND

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Bogart Wealth LLC's ASND Position: Q3 2024 in Review

Bogart Wealth LLC sold out of Ascendis Pharma A/S (ASND) in Q3 2024, closing a stake of 34 shares — an estimated $4.64K sold.

Bogart Wealth LLC first reported a position in ASND in Q1 2023 and held it in 6 quarters. The position peaked at $5.14K in Q1 2024. 219 funds tracked by Wall St. Rank hold ASND as of Q3 2024.

  • Bogart Wealth LLC reported no remaining Ascendis Pharma A/S position as of Q3 2024 after selling out during the quarter.
  • Bogart Wealth LLC sold 34 Ascendis Pharma A/S shares in Q3 2024, an estimated $4.64K.
  • Bogart Wealth LLC first reported a position in Ascendis Pharma A/S in Q1 2023 and held it in 6 quarters.
  • Bogart Wealth LLC's Ascendis Pharma A/S position peaked at $5.14K in Q1 2024.
  • 219 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q3 2024.

Based on Bogart Wealth LLC's 13F filing for Q3 2024, filed 23 Oct 2024.